(Q35094175)

English

The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

based on heuristic

inferred from title

David A. Cairns

3

object named as

David A Cairns

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Naveen S Vasudev

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ioannis Trigonis

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Geoff D Hall

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

David P Jackson

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Timothy Broadhead

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

John Buxton

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Richard Hutson

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

David Nugent

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Timothy J Perren

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

29 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Archives of Gynecology and Obstetrics

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

284

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

221-227

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132454

9 July 2018

Importance of CA125 normalization during neoadjuvant chemotherapy followed by planned delayed surgical debulking in patients with epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132454

9 July 2018

Use of CA-125 to Assess Response to New Agents in Ovarian Cancer Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132454

9 July 2018

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132454

9 July 2018

A prognostic model for ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132454

9 July 2018

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132454

9 July 2018

Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies.

1 reference

https://api.crossref.org/works/10.1007%2FS00404-010-1655-2

21 January 2018

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00404-010-1655-2

21 January 2018

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

1 reference

https://api.crossref.org/works/10.1007%2FS00404-010-1655-2

21 January 2018

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00404-010-1655-2

21 January 2018

Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132454

27 September 2018

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125

1 reference

https://pubmed.ncbi.nlm.nih.gov/20803207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA125 regression during neoadjuvant chemotherapy as an independent prognostic factor for survival in patients with advanced ovarian serous adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20803207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking

1 reference

https://pubmed.ncbi.nlm.nih.gov/20803207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20803207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20803207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20803207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00404-010-1655-2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35094175&oldid=2197239842"